These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37047372)

  • 41. Stem Cell Therapy Offers a Possible Safe and Promising Alternative Approach for Treating Vitiligo: A Review.
    Esquivel D; Mishra R; Srivastava A
    Curr Pharm Des; 2020; 26(37):4815-4821. PubMed ID: 32744962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging role of dermal compartment in skin pigmentation: comprehensive review.
    Kapoor R; Dhatwalia SK; Kumar R; Rani S; Parsad D
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2757-2765. PubMed ID: 32243635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pigment cell transplantation for treatment of vitiligo: a progress report.
    Löntz W; Olsson MJ; Moellmann G; Lerner AB
    J Am Acad Dermatol; 1994 Apr; 30(4):591-7. PubMed ID: 8157785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitiligo: Not Simply a Skin Disease.
    Ahluwalia J; Correa-Selm LM; Rao BK
    Skinmed; 2017; 15(2):125-127. PubMed ID: 28528606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ocular and auditory abnormalities in patients with vitiligo: a case-control study.
    Genedy R; Assal S; Gomaa A; Almakkawy B; Elariny A
    Clin Exp Dermatol; 2021 Aug; 46(6):1058-1066. PubMed ID: 33763919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding Melanocyte Stem Cells for Disease Modeling and Regenerative Medicine Applications.
    Mull AN; Zolekar A; Wang YC
    Int J Mol Sci; 2015 Dec; 16(12):30458-69. PubMed ID: 26703580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repigmentation by combined narrow‑band ultraviolet B/adipose‑derived stem cell transplantation in the mouse model: Role of Nrf2/HO‑1‑mediated Ca
    Bian Y; Yu H; Jin M; Gao X
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34751412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of melanocye-keratinocyte co-culture model for controls and vitiligo to assess regulators of pigmentation and melanocytes.
    Kumar R; Parsad D; Kanwar A; Kaul D
    Indian J Dermatol Venereol Leprol; 2012; 78(5):599-604. PubMed ID: 22960816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of ultraviolet radiation on dermal and epidermal DNA damage in a human pigmented bilayered skin substitute.
    Goyer B; Pereira U; Magne B; Larouche D; Kearns-Turcotte S; Rochette PJ; Martin L; Germain L
    J Tissue Eng Regen Med; 2019 Dec; 13(12):2300-2311. PubMed ID: 31502756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The enigma and challenges of vitiligo pathophysiology and treatment.
    Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Focus Theme Issue: "Vitiligo and other pigmentary disorders".
    Picardo M; Taïeb A
    Exp Dermatol; 2019 Jun; 28(6):639-641. PubMed ID: 31215722
    [No Abstract]   [Full Text] [Related]  

  • 53. Intelligent bioengineering in vitiligo treatment: transdermal protein transduction of melanocyte-lineage-specific genes.
    Mou Y; Jiang X; Du Y; Xue L
    Med Hypotheses; 2012 Dec; 79(6):786-9. PubMed ID: 22999738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dissecting Wnt Signaling for Melanocyte Regulation during Wound Healing.
    Sun Q; Rabbani P; Takeo M; Lee SH; Lim CH; Noel ES; Taketo MM; Myung P; Millar S; Ito M
    J Invest Dermatol; 2018 Jul; 138(7):1591-1600. PubMed ID: 29428355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
    Boniface K; Seneschal J; Picardo M; Taïeb A
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue-engineered skin in the treatment of vitiligo lesions.
    Arenberger P; Broz L; Veselý P; Havlícková B; Matousková E
    Folia Biol (Praha); 2000; 46(4):157-60. PubMed ID: 10954161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
    Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
    J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computerised image analysis of vitiligo lesion: evaluation using manually defined lesion areas.
    Nugroho H; Ahmad Fadzil MH; Shamsudin N; Hussein SH
    Skin Res Technol; 2013 Feb; 19(1):e72-7. PubMed ID: 22233154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generation of human melanocytes from induced pluripotent stem cells.
    Ohta S; Imaizumi Y; Akamatsu W; Okano H; Kawakami Y
    Methods Mol Biol; 2013; 989():193-215. PubMed ID: 23483397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neural differentiation as an expression of UV sensitivity of melanocytes.
    Iyengar B
    Acta Anat (Basel); 1992; 143(3):236-40. PubMed ID: 1632190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.